ClinConnect ClinConnect Logo
Search / Trial NCT06419127

Embryo Assessment Utilizing Timelapse Imaging in Conjunction With Preimplantation Genetic Testing for Aneuploidy With Next Generation Sequencing

Launched by GATTACA GENOMICS · May 14, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Ivf Infertility Pgt Embryo

ClinConnect Summary

This clinical trial is studying how timelapse imaging can help assess embryos during in vitro fertilization (IVF) in combination with a test called preimplantation genetic testing (PGT). The aim is to see if the information gathered from observing embryos over time can provide insights into their genetic health, which is important for couples facing infertility. By using a special incubator that takes pictures of embryos at different stages, researchers hope to find connections between the images and the PGT results, which check for chromosomal abnormalities.

To participate in this study, individuals must be undergoing IVF and have chosen to use PGT. All patients, regardless of age or gender, are welcome to join. If you decide to participate, your embryos will be placed in the timelapse incubator while you undergo the PGT process. This trial is currently recruiting participants, and it offers an opportunity to contribute to research that may improve future fertility treatments.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • all patients undergoing IVF with PGT
  • Exclusion Criteria:
  • patients undergoing IVF and not electing for PGT

About Gattaca Genomics

Gattaca Genomics is a pioneering clinical trial sponsor specializing in genetic and genomic research to advance personalized medicine. With a commitment to enhancing healthcare outcomes, Gattaca leverages cutting-edge genomic technologies and bioinformatics to develop innovative solutions tailored to individual patient needs. The organization collaborates with leading research institutions and healthcare providers to conduct robust clinical trials that aim to uncover novel insights into disease prevention, diagnosis, and treatment, ultimately striving to improve patient care and promote precision health strategies.

Locations

Fort Lauderdale, Florida, United States

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported